ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,224.82
-0.81%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vivos Therapeutics Inc (VVOS)

  7. Vivos Therapeutics Inc (VVOS) News

VVOS Vivos Therapeutics Inc

2.51
0.05 (2.03%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vivos Therapeutics Inc VVOS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.05 2.03% 2.51 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.50 2.48 2.61 2.59 2.46
more quote information »

Recent News

Date Time Source Heading
4/09/202406:30GLOBEVivos Therapeutics’ Flagship CARE Oral Medical Devices..
3/28/202415:05GLOBEVivos Therapeutics Reports Fourth Quarter and Full Year 2023..
3/28/202406:30GLOBEVivos Therapeutics Schedules Release of Fourth Quarter and..
2/15/202407:55EDGAR2Form 8-K - Current report
2/15/202407:00GLOBEVivos Therapeutics Announces Exercise of Warrants for..
2/14/202416:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202406:30GLOBEVivos Therapeutics Highlights Significant Favorable Market..
1/08/202406:30GLOBEVivos Therapeutics Sees Positive Preliminary Metrics..
12/11/202306:30GLOBEVivos Therapeutics Presents Groundbreaking Event:..
12/03/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
12/01/202315:12EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
11/30/202315:05EDGAR2Form 8-K - Current report
11/30/202315:03EDGAR2Form S-1/A - General form for registration of securities..
11/29/202306:30GLOBEVivos Therapeutics Receives First Ever FDA 510(k) Clearance..
11/22/202315:46EDGAR2Form S-1 - General form for registration of securities under..
11/14/202315:05GLOBEVivos Therapeutics Reports Third Quarter 2023 Financial..
11/09/202315:30GLOBEVivos Therapeutics Schedules Release of Third Quarter 2023..
11/03/202316:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/02/202316:10EDGAR2Form 8-K - Current report
11/02/202316:00GLOBEVivos Therapeutics Closes $4 Million Private Placement
10/31/202307:00GLOBEVivos Therapeutics Announces Pricing of $4 Million Private..
10/27/202315:15EDGAR2Form 8-K - Current report
10/26/202306:30GLOBEVivos Therapeutics Announces Reverse Stock Split
10/24/202306:30GLOBEVivos Therapeutics Signs Nationwide Distribution Agreement..
10/11/202306:30GLOBEVivos Therapeutics to Begin Clinical Trial at Stanford..
10/05/202306:30GLOBEVivos Therapeutics Announces Strategic Collaboration in the..
10/04/202314:55APSBiotech Soars On New Agreements
10/04/202306:30GLOBEVivos Therapeutics Executes Strategic Agreements with Ormco..
10/02/202306:30GLOBENew York Times Best-Selling Author James Nestor to Headline..
9/25/202308:00EDGAR2Form 8-K - Current report
9/21/202316:10EDGAR2Form 8-K - Current report
9/14/202315:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/06/202316:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
8/28/202308:00EDGAR2Form DEF 14A - Other definitive proxy statements
8/21/202308:00EDGAR2Form 8-K - Current report
8/16/202315:45EDGAR2Form PRE 14A - Other preliminary proxy statements
8/16/202315:30EDGAR2Form 8-K - Current report
8/16/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/16/202315:05GLOBEVivos Therapeutics Reports Second Quarter 2023 Financial..
8/16/202306:30GLOBEVivos Therapeutics Reschedules Second Quarter 2023 Financial..
8/14/202316:06GLOBEVivos Therapeutics to Reschedule Second Quarter 2023..
8/10/202319:31GLOBEVivos Therapeutics Schedules Release of Second Quarter 2023..
6/08/202315:05GLOBEVivos Therapeutics Reports First Quarter 2023 Financial..
6/06/202315:30GLOBEVivos Therapeutics Schedules Release of First Quarter..
5/09/202306:30GLOBEVivos Therapeutics Announces Additional Strategic..
5/01/202306:30GLOBEClinical Study Shows 92% of Patients Report Resolution of..

Your Recent History

NASDAQ
VVOS
Vivos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved